SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Equifax Inc. (EFX) trades at a trailing P/E of 33.4, forward P/E of 21.5. Trailing earnings yield is 3.00%, forward earnings yield 4.64%. PEG 3.37. Graham Number is $69.11.
Criteria proven by this page:
- VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 21.5 (down from trailing 33.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 3.37 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 3.00% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.64% as earnings recover.
- Analyst consensus target $238.18 (+27.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 57/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EFX
Valuation Multiples
P/E (TTM)33.4
Forward P/E21.5
PEG Ratio3.37
Forward PEG0.34
P/B Ratio4.78
P/S Ratio3.60
EV/EBITDA14.7
Per Share Data
EPS (TTM)$5.44
Forward EPS (Est.)$8.66
Book Value / Share$39.03
Revenue / Share$50.04
FCF / Share$9.34
Yields & Fair Value
Earnings Yield3.00%
Forward Earnings Yield4.64%
Dividend Yield1.14%
Graham Number$69.11
SharesGrow IV$361.44 (+93.9%)
Analyst Target$238.18 (+27.8%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
28.9 |
2.13 |
5.30 |
4.48 |
1.12% |
| 2017 |
24.1 |
1.25 |
4.46 |
4.21 |
1.32% |
| 2018 |
36.1 |
-0.74 |
3.61 |
3.29 |
1.68% |
| 2019 |
-44.1 |
0.19 |
6.57 |
4.83 |
1.11% |
| 2020 |
45.0 |
-0.19 |
7.39 |
5.68 |
0.81% |
| 2021 |
48.0 |
1.12 |
9.96 |
7.25 |
0.53% |
| 2022 |
34.2 |
-4.97 |
6.01 |
4.64 |
0.80% |
| 2023 |
55.7 |
-2.54 |
6.70 |
5.77 |
0.63% |
| 2024 |
52.2 |
5.27 |
6.58 |
5.55 |
0.61% |
| 2025 |
40.5 |
4.12 |
5.81 |
4.40 |
0.87% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.04 |
$3.14B |
$488.8M |
15.5% |
| 2017 |
$4.83 |
$3.36B |
$587.3M |
17.5% |
| 2018 |
$2.47 |
$3.41B |
$299.8M |
8.8% |
| 2019 |
$-3.25 |
$3.51B |
$-392.8M |
-11.2% |
| 2020 |
$4.24 |
$4.13B |
$520.1M |
12.6% |
| 2021 |
$6.02 |
$4.92B |
$744.2M |
15.1% |
| 2022 |
$5.65 |
$5.12B |
$696.2M |
13.6% |
| 2023 |
$4.40 |
$5.27B |
$545.3M |
10.4% |
| 2024 |
$4.84 |
$5.68B |
$604.1M |
10.6% |
| 2025 |
$5.32 |
$6.07B |
$660.3M |
10.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$8.66 |
$8.36 – $9.74 |
$6.75B |
$6.68B – $7.03B |
20 |
| 2027 |
$10.38 |
$9.77 – $12.99 |
$7.4B |
$7.12B – $8.02B |
20 |
| 2028 |
$12.61 |
$11.68 – $13.82 |
$8.09B |
$8.09B – $8.1B |
8 |
| 2029 |
$15.05 |
$14.53 – $16.27 |
$8.64B |
$8.41B – $9.18B |
6 |
| 2030 |
$16.91 |
$16.32 – $18.28 |
$9.02B |
$8.78B – $9.58B |
6 |
